NDC Code(s) : 52125-866-02
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
SpironolactoneSpironolactone TABLET | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: Spironolactone
GENERIC: Spironolactone
DOSAGE: TABLET
ADMINSTRATION: ORAL
NDC: 52125-866-02
COLOR: white
SHAPE: ROUND
SCORE: No score
SIZE: 7 mm
IMPRINT: AN;511
PACKAGING: 30 in 1 BLISTER PACK
ACTIVE INGREDIENT(S):
- SPIRONOLACTONE 25mg in 1
INACTIVE INGREDIENT(S):
- CALCIUM SULFATE DIHYDRATE
- POLYDEXTROSE
- TITANIUM DIOXIDE
- HYPROMELLOSES
- MAGNESIUM STEARATE
- TRIACETIN
- CELLULOSE, MICROCRYSTALLINE
- PEPPERMINT
- STARCH, CORN
- CROSCARMELLOSE SODIUM
- POLYETHYLENE GLYCOL 8000
- POVIDONES